Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder.

Howell LL, Cunningham KA.

Pharmacol Rev. 2015;67(1):176-97. doi: 10.1124/pr.114.009514. Review.

2.
3.

Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder - possible role for methoxyindole pathway.

Zhu H, Bogdanov MB, Boyle SH, Matson W, Sharma S, Matson S, Churchill E, Fiehn O, Rush JA, Krishnan RR, Pickering E, Delnomdedieu M, Kaddurah-Daouk R; Pharmacometabolomics Research Network..

PLoS One. 2013 Jul 17;8(7):e68283. doi: 10.1371/journal.pone.0068283.

4.

Developmental risk I: depression and the developing brain.

Weir JM, Zakama A, Rao U.

Child Adolesc Psychiatr Clin N Am. 2012 Apr;21(2):237-59, vii. doi: 10.1016/j.chc.2012.01.004. Review.

5.

Fluoxetine, desipramine, and the dual antidepressant milnacipran reduce alcohol self-administration and/or relapse in dependent rats.

Simon O'Brien E, Legastelois R, Houchi H, Vilpoux C, Alaux-Cantin S, Pierrefiche O, André E, Naassila M.

Neuropsychopharmacology. 2011 Jun;36(7):1518-30. doi: 10.1038/npp.2011.37.

6.

Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in rats.

Bari A, Theobald DE, Caprioli D, Mar AC, Aidoo-Micah A, Dalley JW, Robbins TW.

Neuropsychopharmacology. 2010 May;35(6):1290-301. doi: 10.1038/npp.2009.233.

8.
9.

Role of 5-hydroxytryptamine2C receptors in Ca2+-dependent ethanol potentiation of GABA release onto ventral tegmental area dopamine neurons.

Theile JW, Morikawa H, Gonzales RA, Morrisett RA.

J Pharmacol Exp Ther. 2009 May;329(2):625-33. doi: 10.1124/jpet.108.147793.

10.

Neurobiological mechanisms of anhedonia.

Gorwood P.

Dialogues Clin Neurosci. 2008;10(3):291-9. Review.

Items per page

Supplemental Content

Support Center